UNSPSC 51101689: Symetine

This classification denotes an antiprotozoal agent with the molecular formula C30H48N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UZ8WTY8051, chemically known as 4,4-(ethylenedioxy(bis(n-hexyl-n-methylbenzylamine) but generally known as symetine, which bears US NIH Compound Identifier 214341. European Medicines Agency schedules Symetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10791MIG. The term SYMETINE is an International Non-Proprietary Name.

UNSPSC 51101689 Symetine is a Commodity code under which state and local governments procure pharmaceutical products, medical supplies, and related therapeutics for emergency response, public health, and institutional healthcare delivery. Recent solicitations show demand for naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products through cooperative purchasing vehicles, and specialized medical and first-aid supplies for fire rescue operations. The code attracts issuing bodies across the public health and emergency services spectrum, including county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances serving multiple jurisdictions.

Activity under the code spans Florida, Texas, and Minnesota, with representation through both single-jurisdiction procurements and multistate cooperative purchasing vehicles. Representative recent opportunities include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to a county health building (response due July 26, 2023); the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs issued April 3, 2026; the City of Tampa's IFB for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 (response due March 13, 2026, sheltered for certified Small Local Business Enterprises with a 5% bid discount); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products serving state and local facilities across Minnesota and Oregon with proposals due March 26, 2026. Cooperative purchasing vehicles and multistate alliances represent a growing channel, as evidenced by MMCAP's involvement spanning multiple jurisdictions and authorized wholesaler networks.